Logo image of ICU

SEASTAR MEDICAL HOLDING CORP (ICU) Stock Fundamental Analysis

NASDAQ:ICU - Nasdaq - US81256L2034 - Common Stock - Currency: USD

1.2601  -0.04 (-3.07%)

Fundamental Rating

1

ICU gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 189 industry peers in the Health Care Equipment & Supplies industry. ICU has a bad profitability rating. Also its financial health evaluation is rather negative. ICU is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ICU had negative earnings in the past year.
In the past year ICU has reported a negative cash flow from operations.
ICU had negative earnings in each of the past 5 years.
ICU had a negative operating cash flow in each of the past 5 years.
ICU Yearly Net Income VS EBIT VS OCF VS FCFICU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

ICU has a Return On Assets of -533.06%. This is amonst the worse of the industry: ICU underperforms 97.88% of its industry peers.
Industry RankSector Rank
ROA -533.06%
ROE N/A
ROIC N/A
ROA(3y)-587.39%
ROA(5y)-528.31%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ICU Yearly ROA, ROE, ROICICU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 500 -500 1K 1.5K

1.3 Margins

The Gross Margin of ICU (100.00%) is better than 100.00% of its industry peers.
The Profit Margin and Operating Margin are not available for ICU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 100%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ICU Yearly Profit, Operating, Gross MarginsICU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -5K -10K -15K

More info and screens

0

2. Health

2.1 Basic Checks

The number of shares outstanding for ICU has been increased compared to 1 year ago.
Compared to 1 year ago, ICU has an improved debt to assets ratio.
ICU Yearly Shares OutstandingICU Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ICU Yearly Total Debt VS Total AssetsICU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

ICU has an Altman-Z score of -54.21. This is a bad value and indicates that ICU is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -54.21, ICU is doing worse than 95.24% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -54.21
ROIC/WACCN/A
WACCN/A
ICU Yearly LT Debt VS Equity VS FCFICU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M -5M -10M -15M

2.3 Liquidity

ICU has a Current Ratio of 0.55. This is a bad value and indicates that ICU is not financially healthy enough and could expect problems in meeting its short term obligations.
ICU has a Current ratio of 0.55. This is amonst the worse of the industry: ICU underperforms 94.18% of its industry peers.
ICU has a Quick Ratio of 0.55. This is a bad value and indicates that ICU is not financially healthy enough and could expect problems in meeting its short term obligations.
ICU has a worse Quick ratio (0.55) than 91.01% of its industry peers.
Industry RankSector Rank
Current Ratio 0.55
Quick Ratio 0.55
ICU Yearly Current Assets VS Current LiabilitesICU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

4

3. Growth

3.1 Past

ICU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 86.78%, which is quite impressive.
EPS 1Y (TTM)86.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.74%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

ICU is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 36.61% yearly.
The Revenue is expected to grow by 202.89% on average over the next years. This is a very strong growth
EPS Next Y80.14%
EPS Next 2Y36.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year358.72%
Revenue Next 2Y202.89%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

ICU Yearly Revenue VS EstimatesICU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 2026 500K 1M 1.5M 2M
ICU Yearly EPS VS EstimatesICU Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 -5 -10 -15 -20 -25

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ICU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ICU is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ICU Price Earnings VS Forward Price EarningsICU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ICU Per share dataICU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3

4.3 Compensation for Growth

ICU's earnings are expected to grow with 36.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.61%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ICU!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SEASTAR MEDICAL HOLDING CORP

NASDAQ:ICU (5/22/2025, 2:45:55 PM)

1.2601

-0.04 (-3.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)08-11 2025-08-11
Inst Owners2.52%
Inst Owner Change120.88%
Ins Owners1.11%
Ins Owner Change0%
Market Cap12.65M
Analysts80
Price Target7.14 (466.62%)
Short Float %2.87%
Short Ratio1.58
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.75%
Min EPS beat(2)-0.12%
Max EPS beat(2)3.62%
EPS beat(4)2
Avg EPS beat(4)1.44%
Min EPS beat(4)-25.41%
Max EPS beat(4)27.67%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-33%
Min Revenue beat(2)-55.78%
Max Revenue beat(2)-10.23%
Revenue beat(4)0
Avg Revenue beat(4)-66.5%
Min Revenue beat(4)-100%
Max Revenue beat(4)-10.23%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)16.13%
EPS NY rev (1m)0%
EPS NY rev (3m)28.84%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 93.71
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.47
EYN/A
EPS(NY)-1.04
Fwd EYN/A
FCF(TTM)-1.59
FCFYN/A
OCF(TTM)-1.59
OCFYN/A
SpS0.01
BVpS-0.22
TBVpS-0.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -533.06%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 100%
FCFM N/A
ROA(3y)-587.39%
ROA(5y)-528.31%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.55
Quick Ratio 0.55
Altman-Z -54.21
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)86.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.74%
EPS Next Y80.14%
EPS Next 2Y36.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year358.72%
Revenue Next 2Y202.89%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-25.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-55.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-55.63%
OCF growth 3YN/A
OCF growth 5YN/A